<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9755">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01692405</url>
  </required_header>
  <id_info>
    <org_study_id>0086-12-EMC</org_study_id>
    <nct_id>NCT01692405</nct_id>
  </id_info>
  <brief_title>Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample</brief_title>
  <official_title>Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UC Care, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UC Care, Ltd.</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Performance evaluation of a novel, semi-automated device and method for needle core biopsy
      download compared to standard methods in terms of:

        1. Biopsy core length obtained (i.e. collecting all tissue fragments)

        2. Biopsy core yield  (i.e. percent of tissue loss during the pathologic processing)

        3. Pathologist interpretability

        4. Processing time

        5. Prostate cancer detection.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>percent of tissue loss</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>percent of biopsy tissue loss during pathologic processing. comparing the core length as recorded on the biopsy needle notch and on the histology slide</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prostate cancer detection rate</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>processing time</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Standard method</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard method- shaking the biopsy needle into a formalin container.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Download onto a biopsy sponge pad</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Samples will be downloaded by moving the needle notch on a biopsy sponge pad.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dowloading the biopsy cores using NavigoBx system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Downloading the biopsy cores using NavigoBx™ system. The NaviGoBx™ device is intended for the retention of a biopsy specimen and for preservation of the specimen's in-needle location and orientation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NaviGo Bx™</intervention_name>
    <description>The NaviGoBx™ system is a device and method that enables an accurate reporting of the exact longitudinal location and direction of the biopsy specimen along the needle notch as well as the accurate length of the specimen. Acquiring this information during the biopsy extraction session provides an accurate designation of the location of any later region of interest within the specimen  itself to the longitudinal position along the needle mandrel.</description>
    <arm_group_label>Dowloading the biopsy cores using NavigoBx system</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biopsy sponge pad</intervention_name>
    <description>the biopsy core is downloaded onto a biopsy sponge pad which is than entered into a biopsy cassette.</description>
    <arm_group_label>Download onto a biopsy sponge pad</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Planned for radical or open prostatectomy operation or Planned for TRUS prostate
             biopsy procedure.

          -  Signed informed consent.

        Exclusion Criteria:

          -  Patient's unwilling to participate.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Haemek madical center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Cohen, Dr.</last_name>
      <phone>04-6494306</phone>
      <email>dr.m.cohen@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Michael Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://hospitals.clalit.co.il/hospitals/emek/he-il/Pages/homepage.aspx</url>
    <description>Haemek medical center home page</description>
  </link>
  <reference>
    <citation>Öbek C, Doğanca T, Erdal S, Erdoğan S, Durak H. Core length in prostate biopsy: size matters. J Urol. 2012 Jun;187(6):2051-5. doi: 10.1016/j.juro.2012.01.075. Epub 2012 Apr 11.</citation>
    <PMID>22498214</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 20, 2012</lastchanged_date>
  <firstreceived_date>September 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
